Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia

Go back to Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
(NASDAQ: EVAX) Delayed: 3.42 +0.37 (12.13%)
Previous Close $3.05    52 Week High
Open $3.14    52 Week Low
Day High $3.64    P/E N/A 
Day Low $3.02    EPS
Volume 27,599